Saturday 7 May 2016
 
»
Tag
 
»
Sanofi

WHO backs Sanofi's vaccine in areas with high dengue rates

The World Health Organization's expert group on immunisation said it recommended that countries consider introducing Sanofi's dengue vaccine Dengvaxia in areas where prevalence of the virus was 50 per cent or higher.  

More…

Sanofi appoints new country chair for Gulf

Sanofi, a global healthcare leader, has appointed Jean-Paul Scheuer as its country chair and general manager, Rx, for Gulf countries, effective March 10. He succeeds Ayman Mokhtar, the company’s former country chair and gene

More…

EDS, Sanofi to address unmet diabetes needs in region

​The Emirates Diabetes Society (EDS) and Sanofi, a healthcare leader, are set to host ‘The Best of ADA (American Diabetes Association) 2015’ in Dubai, UAE, marking the occasion of World Diabetes Day.  

More…

UAE's pharmacovigilance infrastructure in focus

The UAE's Ministry of Health and Sanofi are in a key long-term partnership programme to enhance the pharmacovigilance infrastructure through developing pharmacists' skills, efficiency and performance in alignment with the unified healt

More…

Sanofi in deal to train UAE family physicians

The World Organisation of Family Medicine (Wonca) East Mediterranean Region and Sanofi, a global healthcare leader,  have signed a two-year agreement to deliver a series of educational training sessions to family physicians in the UAE.

More…

Sanofi begins generic drugs production in Dubai

Sanofi, a global and diversified healthcare leader, has announced the start of the first phase of local generic medicines production through Dubai-based Globalpharma at a special ceremony today (October 28). The announcement follo

More…

Final trial confirms Sanofi's dengue vaccine success

French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 per cent in a large final clinical trial. Sanofi has invested more than 1.3 billion euros ($1.7 billion) in

More…

PE firms mull $10bn merger of older GSK, Sanofi brands

Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain's GlaxoSmithKline and France's Sanofi, the Financial Times reported on Sunday, citing sources. U.S.-based KKR and Warbu

More…

Dubai Investments sells 66pc stake in pharma group

Dubai Investments (DI), a leading investment company, said it has sold 66 per cent equity stake in its pharmaceutical subsidiary Globalpharma Company to a group led by healthcare giant Sanofi. Globalpharma is a key manufacturer of

More…

Dubai Investments sells 66pc stake in pharma group

Dubai Investments (DI), a leading investment company, said it has sold 66 per cent equity stake in its pharmaceutical subsidiary Globalpharma Company to a group led by healthcare giant Sanofi. Globalpharma is a key manufacturer of

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads